Taro Pharmaceutical Industries Ltd. shareholder Templeton Asset Management Ltd. has sold its stake in the company for a handsome profit, after fighting on both sides in the years-long legal battle for control of Taro. Templeton sold its shares to Taro controlling shareholder Sun Pharmaceutical Industries Ltd. of India. Sun Pharmaceuticals paid $82 million for Templeton's Taro shake, at $16 per share, a 14% premium on the market price. Sun increased its Taro holding to 65.2% from 53.2%. Templeton invested in Taro in 2005, and increased its stake in 2006, when Taro's share was traded at $12. Templeton bought more shares during 2007 at between $6.50 and $7.20 per share. […]